Abstract
Long-term attempts to create effi cient, targeted medication delivery systems have been delayed by the complexity of the chemical interactions required to build drug delivery systems. Colloidal nanosponges may be adapted to operate with hydrophilic or hydrophobic medicines. This implies that issues with medicine toxicity, reduced bioavailability, and widespread drug release might all be addressed. A nanosponge is a microscopic sponge that can navigate its way to the required location within a living organism. The drug is gently released as the patch clings to the skin of the affl icted region. The nanosponge’s porous construction allows it to trap drug molecules and release them gradually. Perhaps the most exciting development in the pharmaceutical industry is the nanosponge drug delivery device (NSDDS). This review aims to give readers an in-depth look at how nanosponges are made, evaluated, and put to use in the medical fi eld.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
